Advertisement

Index by author

June 01, 1994; Volume 45,Issue 6

A

  1. Aiyar, J

    1. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
      S Grissmer, A N Nguyen, J Aiyar, D C Hanson, R J Mather, G A Gutman, M J Karmilowicz, D D Auperin and K G Chandy
      Molecular Pharmacology June 1994, 45 (6) 1227-1234;

  2. Auperin, D D

    1. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
      S Grissmer, A N Nguyen, J Aiyar, D C Hanson, R J Mather, G A Gutman, M J Karmilowicz, D D Auperin and K G Chandy
      Molecular Pharmacology June 1994, 45 (6) 1227-1234;

B

  1. Balzarini, J

    1. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
      J Balzarini, C Bohman, R T Walker and E de Clercq
      Molecular Pharmacology June 1994, 45 (6) 1253-1258;

  2. Bangalore, R

    1. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
      J Liu, R Bangalore, A Rutledge and D J Triggle
      Molecular Pharmacology June 1994, 45 (6) 1198-1206;

  3. Beaune, P H

    1. Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodies.
      M Bourdi, M Tinel, P H Beaune and D Pessayre
      Molecular Pharmacology June 1994, 45 (6) 1287-1295;

  4. Bend, J R

    1. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids.
      L C Knickle and J R Bend
      Molecular Pharmacology June 1994, 45 (6) 1273-1280;

  5. Biaggioni, I

    1. Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells.
      I Feoktistov, J J Murray and I Biaggioni
      Molecular Pharmacology June 1994, 45 (6) 1160-1167;

  6. Blair, L A

    1. Insulin-like growth factor-I induces a rapid increase in calcium currents and spontaneous membrane activity in clonal pituitary cells.
      R H Selinfreund and L A Blair
      Molecular Pharmacology June 1994, 45 (6) 1215-1220;

  7. Blumberg, P M

    1. Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue.
      C M Seynaeve, M G Kazanietz, P M Blumberg, E A Sausville and P J Worland
      Molecular Pharmacology June 1994, 45 (6) 1207-1214;

  8. Bohman, C

    1. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
      J Balzarini, C Bohman, R T Walker and E de Clercq
      Molecular Pharmacology June 1994, 45 (6) 1253-1258;

  9. Boss, V

    1. L-cysteine sulfinic acid as an endogenous agonist of a novel metabotropic receptor coupled to stimulation of phospholipase D activity.
      V Boss, K M Nutt and P J Conn
      Molecular Pharmacology June 1994, 45 (6) 1177-1182;

  10. Bourdi, M

    1. Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodies.
      M Bourdi, M Tinel, P H Beaune and D Pessayre
      Molecular Pharmacology June 1994, 45 (6) 1287-1295;

  11. Brunton, L L

    1. Coupling of the type A endothelin receptor to multiple responses in adult rat cardiac myocytes.
      R Hilal-Dandan, D T Merck, J P Lujan and L L Brunton
      Molecular Pharmacology June 1994, 45 (6) 1183-1190;

C

  1. Castle, N A

    1. Aminopyridine block of Kv1.1 potassium channels expressed in mammalian cells and Xenopus oocytes.
      N A Castle, S Fadous, D E Logothetis and G K Wang
      Molecular Pharmacology June 1994, 45 (6) 1242-1252;

  2. Chandy, K G

    1. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
      S Grissmer, A N Nguyen, J Aiyar, D C Hanson, R J Mather, G A Gutman, M J Karmilowicz, D D Auperin and K G Chandy
      Molecular Pharmacology June 1994, 45 (6) 1227-1234;

  3. Chao, C C

    1. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repair.
      C C Chao
      Molecular Pharmacology June 1994, 45 (6) 1137-1144;

  4. Christ, M

    1. Palytoxin induces K+ efflux from yeast cells expressing the mammalian sodium pump.
      G Scheiner-Bobis, D Meyer zu Heringdorf, M Christ and E Habermann
      Molecular Pharmacology June 1994, 45 (6) 1132-1136;

  5. Conn, P J

    1. L-cysteine sulfinic acid as an endogenous agonist of a novel metabotropic receptor coupled to stimulation of phospholipase D activity.
      V Boss, K M Nutt and P J Conn
      Molecular Pharmacology June 1994, 45 (6) 1177-1182;

D

  1. Dalman, H M

    1. Multisite interactions of receptors and G proteins: enhanced potency of dimeric receptor peptides in modifying G protein function.
      S M Wade, H M Dalman, S Z Yang and R R Neubig
      Molecular Pharmacology June 1994, 45 (6) 1191-1197;

  2. de Clercq, E

    1. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
      J Balzarini, C Bohman, R T Walker and E de Clercq
      Molecular Pharmacology June 1994, 45 (6) 1253-1258;

  3. Diamond, I

    1. Selective inhibition by ethanol of the type 1 facilitative glucose transporter (GLUT1).
      S W Krauss, I Diamond and A S Gordon
      Molecular Pharmacology June 1994, 45 (6) 1281-1286;

  4. Dilger, J P

    1. Effects of alcohols and volatile anesthetics on the activation of nicotinic acetylcholine receptor channels.
      Y Liu, J P Dilger and A M Vidal
      Molecular Pharmacology June 1994, 45 (6) 1235-1241;

  5. Du, Y L

    1. Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells.
      Y L Du, B D Wilcox, M Teitler and J J Jeffrey
      Molecular Pharmacology June 1994, 45 (6) 1125-1131;

  6. Dudley, D T

    1. The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation.
      G Servant, D T Dudley, E Escher and G Guillemette
      Molecular Pharmacology June 1994, 45 (6) 1112-1118;

E

  1. Escher, E

    1. The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation.
      G Servant, D T Dudley, E Escher and G Guillemette
      Molecular Pharmacology June 1994, 45 (6) 1112-1118;

F

  1. Fadous, S

    1. Aminopyridine block of Kv1.1 potassium channels expressed in mammalian cells and Xenopus oocytes.
      N A Castle, S Fadous, D E Logothetis and G K Wang
      Molecular Pharmacology June 1994, 45 (6) 1242-1252;

  2. Feoktistov, I

    1. Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells.
      I Feoktistov, J J Murray and I Biaggioni
      Molecular Pharmacology June 1994, 45 (6) 1160-1167;

G

  1. Gallo-Rodriguez, C

    1. A binding site model and structure-activity relationships for the rat A3 adenosine receptor.
      P J van Galen, A H van Bergen, C Gallo-Rodriguez, N Melman, M E Olah, A P IJzerman, G L Stiles and K A Jacobson
      Molecular Pharmacology June 1994, 45 (6) 1101-1111;

  2. Garnett, M C

    1. The acidic groups of the neocarzinostatin protein play an important role in its biological activity.
      F Schönlau, W Köhnlein and M C Garnett
      Molecular Pharmacology June 1994, 45 (6) 1268-1272;

  3. Georges, E

    1. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
      B Nare, R K Prichard and E Georges
      Molecular Pharmacology June 1994, 45 (6) 1145-1152;

  4. Gettys, T W

    1. Desensitization of the canine A2a adenosine receptor: delineation of multiple processes.
      T M Palmer, T W Gettys, K A Jacobson and G L Stiles
      Molecular Pharmacology June 1994, 45 (6) 1082-1094;

  5. Gilchrist, T L

    1. Catecholestrogens as mediators of carcinogenesis: correlation of aromatic hydroxylation of estradiol and its fluorinated analogs with tumor induction in Syrian hamsters.
      A C Stalford, J L Maggs, T L Gilchrist and B K Park
      Molecular Pharmacology June 1994, 45 (6) 1259-1267;

  6. Gillard, N P

    1. gamma-Aminobutyric acid type A receptors in the rat brain can contain both gamma 2 and gamma 3 subunits, but gamma 1 does not exist in combination with another gamma subunit.
      K Quirk, N P Gillard, C I Ragan, P J Whiting and R M McKernan
      Molecular Pharmacology June 1994, 45 (6) 1061-1070;

  7. Glaum, S R

    1. Inhibition of phosphoprotein phosphatases blocks metabotropic glutamate receptor effects in the rat nucleus tractus solitarii.
      S R Glaum and R J Miller
      Molecular Pharmacology June 1994, 45 (6) 1221-1226;

  8. Gordon, A S

    1. Selective inhibition by ethanol of the type 1 facilitative glucose transporter (GLUT1).
      S W Krauss, I Diamond and A S Gordon
      Molecular Pharmacology June 1994, 45 (6) 1281-1286;

  9. Grissmer, S

    1. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
      S Grissmer, A N Nguyen, J Aiyar, D C Hanson, R J Mather, G A Gutman, M J Karmilowicz, D D Auperin and K G Chandy
      Molecular Pharmacology June 1994, 45 (6) 1227-1234;

  10. Guillemette, G

    1. The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation.
      G Servant, D T Dudley, E Escher and G Guillemette
      Molecular Pharmacology June 1994, 45 (6) 1112-1118;

  11. Gutman, G A

    1. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
      S Grissmer, A N Nguyen, J Aiyar, D C Hanson, R J Mather, G A Gutman, M J Karmilowicz, D D Auperin and K G Chandy
      Molecular Pharmacology June 1994, 45 (6) 1227-1234;

H

  1. Habermann, E

    1. Palytoxin induces K+ efflux from yeast cells expressing the mammalian sodium pump.
      G Scheiner-Bobis, D Meyer zu Heringdorf, M Christ and E Habermann
      Molecular Pharmacology June 1994, 45 (6) 1132-1136;

  2. Hanson, D C

    1. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
      S Grissmer, A N Nguyen, J Aiyar, D C Hanson, R J Mather, G A Gutman, M J Karmilowicz, D D Auperin and K G Chandy
      Molecular Pharmacology June 1994, 45 (6) 1227-1234;

  3. Hilal-Dandan, R

    1. Coupling of the type A endothelin receptor to multiple responses in adult rat cardiac myocytes.
      R Hilal-Dandan, D T Merck, J P Lujan and L L Brunton
      Molecular Pharmacology June 1994, 45 (6) 1183-1190;

I

  1. IJzerman, A P

    1. A binding site model and structure-activity relationships for the rat A3 adenosine receptor.
      P J van Galen, A H van Bergen, C Gallo-Rodriguez, N Melman, M E Olah, A P IJzerman, G L Stiles and K A Jacobson
      Molecular Pharmacology June 1994, 45 (6) 1101-1111;

J

  1. Jacobson, K A

    1. Desensitization of the canine A2a adenosine receptor: delineation of multiple processes.
      T M Palmer, T W Gettys, K A Jacobson and G L Stiles
      Molecular Pharmacology June 1994, 45 (6) 1082-1094;
    2. A binding site model and structure-activity relationships for the rat A3 adenosine receptor.
      P J van Galen, A H van Bergen, C Gallo-Rodriguez, N Melman, M E Olah, A P IJzerman, G L Stiles and K A Jacobson
      Molecular Pharmacology June 1994, 45 (6) 1101-1111;

  2. Jefcoate, C R

    1. Dual regulation of cytochrome P450EF expression via the aryl hydrocarbon receptor and protein stabilization in C3H/10T1/2 cells.
      U Savas and C R Jefcoate
      Molecular Pharmacology June 1994, 45 (6) 1153-1159;

  3. Jeffrey, J J

    1. Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells.
      Y L Du, B D Wilcox, M Teitler and J J Jeffrey
      Molecular Pharmacology June 1994, 45 (6) 1125-1131;

K

  1. Karmilowicz, M J

    1. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
      S Grissmer, A N Nguyen, J Aiyar, D C Hanson, R J Mather, G A Gutman, M J Karmilowicz, D D Auperin and K G Chandy
      Molecular Pharmacology June 1994, 45 (6) 1227-1234;

  2. Kazanietz, M G

    1. Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue.
      C M Seynaeve, M G Kazanietz, P M Blumberg, E A Sausville and P J Worland
      Molecular Pharmacology June 1994, 45 (6) 1207-1214;

  3. Keefer, J R

    1. Introduction of purified alpha 2A-adrenergic receptors into uniformly oriented, unilamellar, phospholipid vesicles: productive coupling to G proteins but lack of receptor-dependent ion transport.
      J R Keefer, J Nunnari, I H Pang and L E Limbird
      Molecular Pharmacology June 1994, 45 (6) 1071-1081;

  4. Knickle, L C

    1. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids.
      L C Knickle and J R Bend
      Molecular Pharmacology June 1994, 45 (6) 1273-1280;

  5. Köhnlein, W

    1. The acidic groups of the neocarzinostatin protein play an important role in its biological activity.
      F Schönlau, W Köhnlein and M C Garnett
      Molecular Pharmacology June 1994, 45 (6) 1268-1272;

  6. Krauss, S W

    1. Selective inhibition by ethanol of the type 1 facilitative glucose transporter (GLUT1).
      S W Krauss, I Diamond and A S Gordon
      Molecular Pharmacology June 1994, 45 (6) 1281-1286;

L

  1. Limberger, N

    1. Alpha 2-adrenergic receptors of the alpha 2c subtype mediate inhibition of norepinephrine release in human kidney cortex.
      A U Trendelenburg, N Limberger and L C Rump
      Molecular Pharmacology June 1994, 45 (6) 1168-1176;

  2. Limbird, L E

    1. Introduction of purified alpha 2A-adrenergic receptors into uniformly oriented, unilamellar, phospholipid vesicles: productive coupling to G proteins but lack of receptor-dependent ion transport.
      J R Keefer, J Nunnari, I H Pang and L E Limbird
      Molecular Pharmacology June 1994, 45 (6) 1071-1081;

  3. Liu, J

    1. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
      J Liu, R Bangalore, A Rutledge and D J Triggle
      Molecular Pharmacology June 1994, 45 (6) 1198-1206;

  4. Liu, Y

    1. Effects of alcohols and volatile anesthetics on the activation of nicotinic acetylcholine receptor channels.
      Y Liu, J P Dilger and A M Vidal
      Molecular Pharmacology June 1994, 45 (6) 1235-1241;

  5. Logothetis, D E

    1. Aminopyridine block of Kv1.1 potassium channels expressed in mammalian cells and Xenopus oocytes.
      N A Castle, S Fadous, D E Logothetis and G K Wang
      Molecular Pharmacology June 1994, 45 (6) 1242-1252;

  6. Lujan, J P

    1. Coupling of the type A endothelin receptor to multiple responses in adult rat cardiac myocytes.
      R Hilal-Dandan, D T Merck, J P Lujan and L L Brunton
      Molecular Pharmacology June 1994, 45 (6) 1183-1190;

M

  1. Maggs, J L

    1. Catecholestrogens as mediators of carcinogenesis: correlation of aromatic hydroxylation of estradiol and its fluorinated analogs with tumor induction in Syrian hamsters.
      A C Stalford, J L Maggs, T L Gilchrist and B K Park
      Molecular Pharmacology June 1994, 45 (6) 1259-1267;

  2. Mather, R J

    1. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
      S Grissmer, A N Nguyen, J Aiyar, D C Hanson, R J Mather, G A Gutman, M J Karmilowicz, D D Auperin and K G Chandy
      Molecular Pharmacology June 1994, 45 (6) 1227-1234;

  3. McKernan, R M

    1. gamma-Aminobutyric acid type A receptors in the rat brain can contain both gamma 2 and gamma 3 subunits, but gamma 1 does not exist in combination with another gamma subunit.
      K Quirk, N P Gillard, C I Ragan, P J Whiting and R M McKernan
      Molecular Pharmacology June 1994, 45 (6) 1061-1070;

  4. Melman, N

    1. A binding site model and structure-activity relationships for the rat A3 adenosine receptor.
      P J van Galen, A H van Bergen, C Gallo-Rodriguez, N Melman, M E Olah, A P IJzerman, G L Stiles and K A Jacobson
      Molecular Pharmacology June 1994, 45 (6) 1101-1111;

  5. Merck, D T

    1. Coupling of the type A endothelin receptor to multiple responses in adult rat cardiac myocytes.
      R Hilal-Dandan, D T Merck, J P Lujan and L L Brunton
      Molecular Pharmacology June 1994, 45 (6) 1183-1190;

  6. Meyer zu Heringdorf, D

    1. Palytoxin induces K+ efflux from yeast cells expressing the mammalian sodium pump.
      G Scheiner-Bobis, D Meyer zu Heringdorf, M Christ and E Habermann
      Molecular Pharmacology June 1994, 45 (6) 1132-1136;

  7. Miller, R J

    1. Inhibition of phosphoprotein phosphatases blocks metabotropic glutamate receptor effects in the rat nucleus tractus solitarii.
      S R Glaum and R J Miller
      Molecular Pharmacology June 1994, 45 (6) 1221-1226;

  8. Murray, J J

    1. Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells.
      I Feoktistov, J J Murray and I Biaggioni
      Molecular Pharmacology June 1994, 45 (6) 1160-1167;

N

  1. Nare, B

    1. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
      B Nare, R K Prichard and E Georges
      Molecular Pharmacology June 1994, 45 (6) 1145-1152;

  2. Neubig, R R

    1. Multisite interactions of receptors and G proteins: enhanced potency of dimeric receptor peptides in modifying G protein function.
      S M Wade, H M Dalman, S Z Yang and R R Neubig
      Molecular Pharmacology June 1994, 45 (6) 1191-1197;

  3. Nguyen, A N

    1. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
      S Grissmer, A N Nguyen, J Aiyar, D C Hanson, R J Mather, G A Gutman, M J Karmilowicz, D D Auperin and K G Chandy
      Molecular Pharmacology June 1994, 45 (6) 1227-1234;

  4. Nunnari, J

    1. Introduction of purified alpha 2A-adrenergic receptors into uniformly oriented, unilamellar, phospholipid vesicles: productive coupling to G proteins but lack of receptor-dependent ion transport.
      J R Keefer, J Nunnari, I H Pang and L E Limbird
      Molecular Pharmacology June 1994, 45 (6) 1071-1081;

  5. Nutt, K M

    1. L-cysteine sulfinic acid as an endogenous agonist of a novel metabotropic receptor coupled to stimulation of phospholipase D activity.
      V Boss, K M Nutt and P J Conn
      Molecular Pharmacology June 1994, 45 (6) 1177-1182;

  6. Nutter, L M

    1. 2',3'-Dideoxycytidine alters calcium buffering in cultured dorsal root ganglion neurons.
      J L Werth, B Zhou, L M Nutter and S A Thayer
      Molecular Pharmacology June 1994, 45 (6) 1119-1124;

O

  1. Olah, M E

    1. A binding site model and structure-activity relationships for the rat A3 adenosine receptor.
      P J van Galen, A H van Bergen, C Gallo-Rodriguez, N Melman, M E Olah, A P IJzerman, G L Stiles and K A Jacobson
      Molecular Pharmacology June 1994, 45 (6) 1101-1111;

P

  1. Palmer, T M

    1. Desensitization of the canine A2a adenosine receptor: delineation of multiple processes.
      T M Palmer, T W Gettys, K A Jacobson and G L Stiles
      Molecular Pharmacology June 1994, 45 (6) 1082-1094;

  2. Pang, I H

    1. Introduction of purified alpha 2A-adrenergic receptors into uniformly oriented, unilamellar, phospholipid vesicles: productive coupling to G proteins but lack of receptor-dependent ion transport.
      J R Keefer, J Nunnari, I H Pang and L E Limbird
      Molecular Pharmacology June 1994, 45 (6) 1071-1081;

  3. Park, B K

    1. Catecholestrogens as mediators of carcinogenesis: correlation of aromatic hydroxylation of estradiol and its fluorinated analogs with tumor induction in Syrian hamsters.
      A C Stalford, J L Maggs, T L Gilchrist and B K Park
      Molecular Pharmacology June 1994, 45 (6) 1259-1267;

  4. Pessayre, D

    1. Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodies.
      M Bourdi, M Tinel, P H Beaune and D Pessayre
      Molecular Pharmacology June 1994, 45 (6) 1287-1295;

  5. Prichard, R K

    1. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
      B Nare, R K Prichard and E Georges
      Molecular Pharmacology June 1994, 45 (6) 1145-1152;

Q

  1. Quirk, K

    1. gamma-Aminobutyric acid type A receptors in the rat brain can contain both gamma 2 and gamma 3 subunits, but gamma 1 does not exist in combination with another gamma subunit.
      K Quirk, N P Gillard, C I Ragan, P J Whiting and R M McKernan
      Molecular Pharmacology June 1994, 45 (6) 1061-1070;

R

  1. Ragan, C I

    1. gamma-Aminobutyric acid type A receptors in the rat brain can contain both gamma 2 and gamma 3 subunits, but gamma 1 does not exist in combination with another gamma subunit.
      K Quirk, N P Gillard, C I Ragan, P J Whiting and R M McKernan
      Molecular Pharmacology June 1994, 45 (6) 1061-1070;

  2. Rump, L C

    1. Alpha 2-adrenergic receptors of the alpha 2c subtype mediate inhibition of norepinephrine release in human kidney cortex.
      A U Trendelenburg, N Limberger and L C Rump
      Molecular Pharmacology June 1994, 45 (6) 1168-1176;

  3. Rutledge, A

    1. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
      J Liu, R Bangalore, A Rutledge and D J Triggle
      Molecular Pharmacology June 1994, 45 (6) 1198-1206;

S

  1. Sausville, E A

    1. Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue.
      C M Seynaeve, M G Kazanietz, P M Blumberg, E A Sausville and P J Worland
      Molecular Pharmacology June 1994, 45 (6) 1207-1214;

  2. Savas, U

    1. Dual regulation of cytochrome P450EF expression via the aryl hydrocarbon receptor and protein stabilization in C3H/10T1/2 cells.
      U Savas and C R Jefcoate
      Molecular Pharmacology June 1994, 45 (6) 1153-1159;

  3. Scheiner-Bobis, G

    1. Palytoxin induces K+ efflux from yeast cells expressing the mammalian sodium pump.
      G Scheiner-Bobis, D Meyer zu Heringdorf, M Christ and E Habermann
      Molecular Pharmacology June 1994, 45 (6) 1132-1136;

  4. Schönlau, F

    1. The acidic groups of the neocarzinostatin protein play an important role in its biological activity.
      F Schönlau, W Köhnlein and M C Garnett
      Molecular Pharmacology June 1994, 45 (6) 1268-1272;

  5. Selinfreund, R H

    1. Insulin-like growth factor-I induces a rapid increase in calcium currents and spontaneous membrane activity in clonal pituitary cells.
      R H Selinfreund and L A Blair
      Molecular Pharmacology June 1994, 45 (6) 1215-1220;

  6. Servant, G

    1. The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation.
      G Servant, D T Dudley, E Escher and G Guillemette
      Molecular Pharmacology June 1994, 45 (6) 1112-1118;

  7. Seynaeve, C M

    1. Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue.
      C M Seynaeve, M G Kazanietz, P M Blumberg, E A Sausville and P J Worland
      Molecular Pharmacology June 1994, 45 (6) 1207-1214;

  8. Shenk, T

    1. Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: modulation of transcription.
      M Toth and T Shenk
      Molecular Pharmacology June 1994, 45 (6) 1095-1100;

  9. Stalford, A C

    1. Catecholestrogens as mediators of carcinogenesis: correlation of aromatic hydroxylation of estradiol and its fluorinated analogs with tumor induction in Syrian hamsters.
      A C Stalford, J L Maggs, T L Gilchrist and B K Park
      Molecular Pharmacology June 1994, 45 (6) 1259-1267;

  10. Stiles, G L

    1. Desensitization of the canine A2a adenosine receptor: delineation of multiple processes.
      T M Palmer, T W Gettys, K A Jacobson and G L Stiles
      Molecular Pharmacology June 1994, 45 (6) 1082-1094;
    2. A binding site model and structure-activity relationships for the rat A3 adenosine receptor.
      P J van Galen, A H van Bergen, C Gallo-Rodriguez, N Melman, M E Olah, A P IJzerman, G L Stiles and K A Jacobson
      Molecular Pharmacology June 1994, 45 (6) 1101-1111;

T

  1. Teitler, M

    1. Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells.
      Y L Du, B D Wilcox, M Teitler and J J Jeffrey
      Molecular Pharmacology June 1994, 45 (6) 1125-1131;

  2. Thayer, S A

    1. 2',3'-Dideoxycytidine alters calcium buffering in cultured dorsal root ganglion neurons.
      J L Werth, B Zhou, L M Nutter and S A Thayer
      Molecular Pharmacology June 1994, 45 (6) 1119-1124;

  3. Tinel, M

    1. Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodies.
      M Bourdi, M Tinel, P H Beaune and D Pessayre
      Molecular Pharmacology June 1994, 45 (6) 1287-1295;

  4. Toth, M

    1. Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: modulation of transcription.
      M Toth and T Shenk
      Molecular Pharmacology June 1994, 45 (6) 1095-1100;

  5. Trendelenburg, A U

    1. Alpha 2-adrenergic receptors of the alpha 2c subtype mediate inhibition of norepinephrine release in human kidney cortex.
      A U Trendelenburg, N Limberger and L C Rump
      Molecular Pharmacology June 1994, 45 (6) 1168-1176;

  6. Triggle, D J

    1. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
      J Liu, R Bangalore, A Rutledge and D J Triggle
      Molecular Pharmacology June 1994, 45 (6) 1198-1206;

V

  1. van Bergen, A H

    1. A binding site model and structure-activity relationships for the rat A3 adenosine receptor.
      P J van Galen, A H van Bergen, C Gallo-Rodriguez, N Melman, M E Olah, A P IJzerman, G L Stiles and K A Jacobson
      Molecular Pharmacology June 1994, 45 (6) 1101-1111;

  2. van Galen, P J

    1. A binding site model and structure-activity relationships for the rat A3 adenosine receptor.
      P J van Galen, A H van Bergen, C Gallo-Rodriguez, N Melman, M E Olah, A P IJzerman, G L Stiles and K A Jacobson
      Molecular Pharmacology June 1994, 45 (6) 1101-1111;

  3. Vidal, A M

    1. Effects of alcohols and volatile anesthetics on the activation of nicotinic acetylcholine receptor channels.
      Y Liu, J P Dilger and A M Vidal
      Molecular Pharmacology June 1994, 45 (6) 1235-1241;

W

  1. Wade, S M

    1. Multisite interactions of receptors and G proteins: enhanced potency of dimeric receptor peptides in modifying G protein function.
      S M Wade, H M Dalman, S Z Yang and R R Neubig
      Molecular Pharmacology June 1994, 45 (6) 1191-1197;

  2. Walker, R T

    1. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
      J Balzarini, C Bohman, R T Walker and E de Clercq
      Molecular Pharmacology June 1994, 45 (6) 1253-1258;

  3. Wang, G K

    1. Aminopyridine block of Kv1.1 potassium channels expressed in mammalian cells and Xenopus oocytes.
      N A Castle, S Fadous, D E Logothetis and G K Wang
      Molecular Pharmacology June 1994, 45 (6) 1242-1252;

  4. Werth, J L

    1. 2',3'-Dideoxycytidine alters calcium buffering in cultured dorsal root ganglion neurons.
      J L Werth, B Zhou, L M Nutter and S A Thayer
      Molecular Pharmacology June 1994, 45 (6) 1119-1124;

  5. Whiting, P J

    1. gamma-Aminobutyric acid type A receptors in the rat brain can contain both gamma 2 and gamma 3 subunits, but gamma 1 does not exist in combination with another gamma subunit.
      K Quirk, N P Gillard, C I Ragan, P J Whiting and R M McKernan
      Molecular Pharmacology June 1994, 45 (6) 1061-1070;

  6. Wilcox, B D

    1. Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells.
      Y L Du, B D Wilcox, M Teitler and J J Jeffrey
      Molecular Pharmacology June 1994, 45 (6) 1125-1131;

  7. Worland, P J

    1. Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue.
      C M Seynaeve, M G Kazanietz, P M Blumberg, E A Sausville and P J Worland
      Molecular Pharmacology June 1994, 45 (6) 1207-1214;

Y

  1. Yang, S Z

    1. Multisite interactions of receptors and G proteins: enhanced potency of dimeric receptor peptides in modifying G protein function.
      S M Wade, H M Dalman, S Z Yang and R R Neubig
      Molecular Pharmacology June 1994, 45 (6) 1191-1197;

Z

  1. Zhou, B

    1. 2',3'-Dideoxycytidine alters calcium buffering in cultured dorsal root ganglion neurons.
      J L Werth, B Zhou, L M Nutter and S A Thayer
      Molecular Pharmacology June 1994, 45 (6) 1119-1124;
Back to top

In this issue

Advertisement